Company logo

COO - The Cooper Companies, Inc.

NYSE -> Healthcare -> Medical Instruments & Supplies
San Ramon, United States
Type: Equity

COO price evolution
COO
(in millions $) 2 Mar 2024 1 Dec 2023 31 Aug 2023 30 May 2023
Current assets
Cash $135.2 $120.8 $117.3
Short term investments
Net receivables $651 $609.7 $629.9 $564.7
Inventory $747.5 $735.6 $723.6 $699
Total current assets $1793.9 $1704.9 $1711 $1599.3
Long term investments
Property, plant & equipment $1682.2 $1632.6 $1535 $1489.8
Goodwill & intangible assets $5621.3 $5334.8 $5453.7
Total noncurrent assets $10238.7 $9954 $9986.3
Total investments
Total assets $12032.6 $11658.9 $11697.3 $11539.5
Current liabilities
Accounts payable $202.3 $261.9 $226.7 $242.4
Deferred revenue $308.7 $307.8 $308.3
Short long term debt $46.1 $45.4 $79.6
Total current liabilities $964.9 $969 $993.6 $949.1
Long term debt $2726.2 $2523.8 $2514.7 $2565.7
Total noncurrent liabilities $3372.4 $3138.9 $3175.2
Total debt $2772.3 $2569.2 $2594.3
Total liabilities $4337.5 $4107.9 $4169 $4161.5
Shareholders' equity
Retained earnings $6957.3 $6876.1 $6791.6 $6707.8
Other shareholder equity -$422 $7551 -$374.8 $7378
Total shareholder equity $7695.1 $7550.8 $7528.3
(in millions $) 31 Dec 2023 1 Dec 2022 31 Dec 2021 31 Dec 2020
Current assets
Cash $120.8 $138.2 $95.9 $115.9
Short term investments
Net receivables $609.7 $557.8 $515.3 $435.4
Inventory $735.6 $628.7 $585.6 $570.4
Total current assets $1704.9 $1533.6 $1465.3 $1274.2
Long term investments
Property, plant & equipment $1632.6 $1663 $1604.6 $1542.1
Goodwill & intangible assets $5334.8 $5494.8 $3845.5 $3736.3
Total noncurrent assets $9954 $9958.7 $8140.9 $5463.3
Total investments
Total assets $11658.9 $11492.3 $9606.2 $6737.5
Current liabilities
Accounts payable $352.1 $248.8 $301 $338
Deferred revenue $307.8 $291.9
Short long term debt $45.4 $412.6 $118.6 $442.6
Total current liabilities $969 $1280.2 $732.1 $1004.4
Long term debt $2523.8 $2350.8 $1627.8 $1620.7
Total noncurrent liabilities $3138.9 $3037.4 $1932.1 $1908.3
Total debt $2569.2 $2763.4 $1746.4 $2063.3
Total liabilities $4107.9 $4317.8 $2664.2 $2912.7
Shareholders' equity
Retained earnings $6876.1 $6584.9 $6202.1 $3261.8
Other shareholder equity -$453.8 -$466.8 -$341.3 -$472
Total shareholder equity $7550.8 $7174.5 $6941.8 $3824.6
(in millions $) 2 Mar 2024 1 Dec 2023 31 Aug 2023 30 May 2023
Revenue
Total revenue $931.6 $927.1 $930.2 $877.4
Cost of revenue
Gross Profit $623.8 $606.5 $610 $582.9
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $470.7 $470.8 $458.4 $486.6
Operating income
Income from continuing operations
EBIT
Income tax expense $38.8 $21.9 $33.5 $25.8
Interest expense -$31.1 -$26.3 -$31.1 -$26.1
Net income
Net income $81.2 $84.5 $85.3 $39.8
Income (for common shares)
(in millions $) 31 Dec 2023 31 Dec 2022 31 Jan 2022 31 Dec 2020
Revenue
Total revenue $3593.2 $3308.4 $2430.9
Cost of revenue $1235.3 $1168.8 $896.1
Gross Profit $2357.9 $2139.6 $1534.8
Operating activities
Research & development $137.4 $110.3 $93.3
Selling, general & administrative $1501.2 $1342.2 $992.5
Total operating expenses $1824.8 $1632 $1223
Operating income $533.1 $507.6 $311.8
Income from continuing operations
EBIT $518.2 $532.6 $303.3
Income tax expense $118.7 $89.5 $28.1
Interest expense $105.3 $57.3 $36.8
Net income
Net income $294.2 $385.8 $238.4
Income (for common shares) $294.2 $385.8 $238.4
(in millions $) 2 Mar 2024 1 Dec 2023 31 Aug 2023 30 May 2023
Net income
Operating activities
Depreciation
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations
Investing activities
Capital expenditures
Investments
Total cash flows from investing -$324.1 -$449 -$288.2 -$195.3
Financing activities
Dividends paid -$3 -$1.5 -$1.5
Sale and purchase of stock
Net borrowings
Total cash flows from financing $212.3 -$173.9 -$167.4 -$124.4
Effect of exchange rate $3.5 -$2.3 $1.2 $2.4
Change in cash and equivalents $14.4 -$17.7 -$21.1 -$26.5
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income $294.2 $385.8 $2944.7 $238.4
Operating activities
Depreciation $407.7 $378.3 $343.1 $319.6
Business acquisitions & disposals -$56.5 -$1589.2 -$235.9 -$54.1
Stock-based compensation $62.1 $54.2 $43.8 $37.6
Total cash flows from operations $607.5 $692.4 $738.6 $486.6
Investing activities
Capital expenditures -$392.5 -$242 -$214.4 -$310.4
Investments
Total cash flows from investing -$449 -$1831.2 -$450.3 -$364.5
Financing activities
Dividends paid -$3 -$3 -$3 -$3
Sale and purchase of stock $9.9 -$79.2 $1.5 -$51.9
Net borrowings -$180.8 $1278.8 -$309.8 -$37.1
Total cash flows from financing -$173.9 $1193.7 -$311.4 -$95.5
Effect of exchange rate -$2.3 -$12.9 $2.9 $0.7
Change in cash and equivalents -$17.7 $42 -$20.2 $27.3
Fundamentals
Market cap $20.24B
Enterprise value N/A
Shares outstanding 198.70M
Revenue $3.67B
EBITDA N/A
EBIT N/A
Net Income $290.80M
Revenue Q/Q 8.51%
Revenue Y/Y N/A
P/E ratio 69.59
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio 5.52
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS $1.46
ROA 2.48%
ROE N/A
Debt/Equity 0.54
Net debt/EBITDA N/A
Current ratio 1.86
Quick ratio 1.08